29 March 2017
News and Views
Links and Services
The most recent issue of Gut evaluates the association between acid-suppressive medications, and risk of esophageal adenocarcinoma or high-grade dysplasia in patients with Barrett's esophagus.
Acid-suppressive medications, particularly proton pump inhibitors (PPIs), may decrease the risk o
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors